Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Disallow: /wp-includes/ Disallow: /wp-content/plugins/ Disallow: /wp-admin/ Disallow: /wp-includes/ Disallow: /readme.html Disallow: /refer/ Disallow: /trackback/ Disallow: /xmlrpc.php Disallow: /feed/ Allow: /wp-admin/admin-ajax.php Allow: /wp-content/uploads/ Allow: /wp-content/themes/*js? Allow: /wp-content/themes/*css? Allow: /wp-content/plugins/*js? Allow: /wp-content/plugins/*css? User-agent: Mediapartners-Google* Allow: / User-agent: Googlebot-Image Disallow: /wp-content/uploads/ User-agent: Adsbot-Google Allow: / User-agent: Googlebot-Mobile Allow: / Sitemap: https://kadmon.com/page-sitemap.xml Disallow: https://kadmon.com/wp-content/uploads/wpo-plugins-tables-list.json |
Title | Developing transformative therapies for immune disorders, fibrotic diseases and cancer - Kadmon, a |
Description | Toggle Navigation Search: About Us Our Company Kadmon Commitment Contact Clinical Pipeline Pipeline About cGVHD About Belumosudil About KD033 Clinical Tri |
Keywords | N/A |
WebSite | kadmon.com |
Host IP | 64.207.154.158 |
Location | United States |
Site | Rank |
US$1,911
Last updated: 2022-07-04 22:59:11
kadmon.com has Semrush global rank of 0. kadmon.com has an estimated worth of US$ 1,911, based on its estimated Ads revenue. kadmon.com receives approximately 220 unique visitors each day. Its web server is located in United States, with IP address 64.207.154.158. According to SiteAdvisor, kadmon.com is safe to visit. |
Purchase/Sale Value | US$1,911 |
Daily Ads Revenue | US$1 |
Monthly Ads Revenue | US$52 |
Yearly Ads Revenue | US$635 |
Daily Unique Visitors | 14 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
kadmon.com. | A | 7199 | IP: 64.207.154.158 |
kadmon.com. | NS | 86400 | NS Record: edns4.ultradns.org. |
kadmon.com. | NS | 86400 | NS Record: edns4.ultradns.com. |
kadmon.com. | NS | 86400 | NS Record: edns4.ultradns.net. |
kadmon.com. | NS | 86400 | NS Record: edns4.ultradns.biz. |
kadmon.com. | MX | 3600 | MX Record: 10 us-smtp-inbound-1.mimecast.com. |
kadmon.com. | MX | 3600 | MX Record: 10 us-smtp-inbound-2.mimecast.com. |
kadmon.com. | TXT | 3600 | TXT Record: kogniB/XnugdNZFxQelMo6U8QwTT/FCtbBwvBRbm4KtwX/0UoD6AcQ7uB4krHLaHWlAH0/5PgjKv2bZsi5ZBIA== |
kadmon.com. | TXT | 3600 | TXT Record: MS=B1BCBBDEB0B6561299B6A0DBEB038DE61F6E6E51 |
kadmon.com. | TXT | 3600 | TXT Record: docusign=7f32c10d-b357-4f73-a4a9-2faff77e3f81 |
kadmon.com. | TXT | 3600 | TXT Record: v=spf1 a mx ip4:209.114.182.0/24 ip4:4.53.85.240/28 ip4:160.72.170.0/24 ip4:208.75.120.0/22 include:us._netblocks.mimecast.com include:spf.protection.outlook.com -all |
Toggle Navigation Search: About Us Our Company Kadmon Commitment Contact Clinical Pipeline Pipeline About cGVHD About Belumosudil About KD033 Clinical Trials Science Preclinical Pipeline Biologics Monoclonal Antibody Discovery Platform IL-15 Platform Small Molecules Structure-Based Drug Design Publications and Posters Products Careers Search: Contact Developing transformative therapies for immune disorders, fibrotic diseases and cancer About Us Kadmon, a Sanofi Company, is a biopharmaceutical company that discovers, develops and markets transformative therapies for unmet medical needs. Our clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies. Learn More News View Press Release REZUROCK ™ (belumosudil) tablets Full Prescribing Information Visit www.rezurock.com Clinical Pipeline Product Indication Status REZUROCK ™ (belumosudil) (Selective ROCK2 inhibitor) Chronic Graft-Versus-Host Disease (cGVHD) FDA approved for the treatment of |
HTTP/1.1 301 Moved Permanently Server: nginx Date: Thu, 28 Oct 2021 21:31:31 GMT Content-Type: text/html; charset=UTF-8 Connection: keep-alive X-Powered-By: PHP/7.0.33 Expires: Thu, 28 Oct 2021 22:31:31 GMT Cache-Control: max-age=3600 X-Redirect-By: WordPress Location: https://kadmon.com/ X-Powered-By: PleskLin HTTP/2 200 server: nginx date: Thu, 28 Oct 2021 21:31:31 GMT content-type: text/html; charset=UTF-8 content-length: 36074 last-modified: Fri, 01 Oct 2021 12:07:29 GMT accept-ranges: bytes vary: Accept-Encoding cache-control: max-age=0, no-cache, no-store, must-revalidate pragma: no-cache expires: Mon, 29 Oct 1923 20:30:00 GMT x-powered-by: PleskLin |
Domain Name: KADMON.COM Registry Domain ID: 85469035_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-04-11T12:10:44Z Creation Date: 2002-04-10T20:52:17Z Registry Expiry Date: 2022-04-10T20:52:17Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: EDNS4.ULTRADNS.BIZ Name Server: EDNS4.ULTRADNS.COM Name Server: EDNS4.ULTRADNS.NET Name Server: EDNS4.ULTRADNS.ORG DNSSEC: unsigned >>> Last update of whois database: 2021-09-16T12:51:37Z <<< |